1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics, August 2016

Biotechnology Analysis & Statistics, August 2016

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

1-30 of about 6 500 reports

Purchase Reports From Reputable Market Research Publishers

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cance ...

  • Industries : Cancer, Pathology
  • Countries : United States
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016’, provides an overview of the Retinitis Pigmentosa ...

  • Industries : Therapy, Pathology, Research and Development, Biological Therapy
  • Countries : United States
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hospital Acquired Methicillin-Resistant Staphylococcus ...

  • Industries : Therapy
  • Countries : World, United Kingdom, United States
Poliomyelitis - Pipeline Review, H1 2016

Poliomyelitis - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Poliomyelitis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Poliomyelitis - Pipeline Review, H1 2016’, provides an overview of the Poliomyelitis pipeline landscape. The report provides ...

  • Industries : Pathology, Therapy, Biopharmaceutical, Healthcare
  • Countries : United States, World
Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Sangamo BioSciences, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sangamo BioSciences, ...

  • Industries : Research and Development, Biological Therapy, Therapy, Pathology
  • Countries : United States
Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016

Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016’, provides ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, ...

  • Industries : Pathology, Therapy, Pharmaceutical, Healthcare
  • Countries : United States
Toxoplasmosis - Pipeline Review, H1 2016

Toxoplasmosis - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Toxoplasmosis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Toxoplasmosis - Pipeline Review, H1 2016’, provides an overview of the Toxoplasmosis pipeline landscape. The report provides ...

  • Industries : Pathology, Biopharmaceutical, Therapy
  • Countries : World
Nanotherapeutics, Inc. - Product Pipeline Review - 2016

Nanotherapeutics, Inc. - Product Pipeline Review - 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Nanotherapeutics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Nanotherapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Nanotherapeutics, Inc.’s ...

  • Industries : Therapy
  • Countries : United States
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, Therapy, Healthcare, Pharmaceutical
  • Countries : United States
Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Streptococcal Pneumonia - Pipeline Review, H1 2016

Streptococcal Pneumonia - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Streptococcal Pneumonia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Streptococcal Pneumonia - Pipeline Review, H1 2016’, provides an overview of the Streptococcal Pneumonia pipeline ...

  • Industries : Pathology, Biopharmaceutical, Therapy, Healthcare, Biotechnology
  • Countries : World
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016’, provides an overview of the Live ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016’, provides an overview of the Herpes ...

  • Industries : Therapy, Biopharmaceutical, Research and Development, Pharmaceutical, Biotechnology, Pathology
  • Countries : United States
Age Related Macular Degeneration - Pipeline Review, H1 2016

Age Related Macular Degeneration - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Age Related ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016’, provides an overview of ...

  • Industries : Therapy, Biopharmaceutical, Biological Therapy, Biotechnology
  • Countries : United States
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016’, provides an overview of the Metachromatic ...

  • Industries : Mental Health
  • Countries : United States, World
Global Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

Global Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. VPGMarketResearch.com's new report is a study of the major business opportunities emerging in the global cance ...

  • Industries : Biopharmaceutical
  • Countries : United States
Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

  • $ 15 900
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $24,500.  DataPack (test volumes, sales forecasts, supplier shares) $15,900. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the global cance ...

  • Industries : Biopharmaceutical
Europe Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

Europe Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 12 800
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

  • Industries : Biopharmaceutical
Tumor Markers: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Tumor Markers: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 12 800
  • Industry report
  • June 2016
  • by Venture Planning Group

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. Summary This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the ...

  • Industries : Biopharmaceutical
Cancer Diagnostics Market:  France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics Market: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 12 800
  • Industry report
  • June 2016
  • by Venture Planning Group

This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The ...

  • Industries : Biopharmaceutical
  • Countries : France
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

  • Industries : Therapy, Cancer
  • Countries : Europe, United States, Spain, United Kingdom, France
Psoriatic Arthritis Pricing, Reimbursement, and Access

Psoriatic Arthritis Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • June 2016
  • by Datamonitor Healthcare

An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...

  • Industries : Pathology, Healthcare
  • Countries : Europe, Spain, Germany, Italy
Medical Affiars Reputation: Multiple Sclerosis (US)

Medical Affiars Reputation: Multiple Sclerosis (US)

  • $ 6 320
  • Industry report
  • June 2016
  • by Firstword Pharma

MS medical affairs: oral therapies outperforming in the US. How does your team measure up? In the US multiple sclerosis (MS) market, medical affairs teams for oral therapies outperform their platform-therapy ...

  • Industries : Biopharmaceutical
Medical Affiars Reputation: Multiple Sclerosis (EU5)

Medical Affiars Reputation: Multiple Sclerosis (EU5)

  • $ 6 320
  • Industry report
  • June 2016
  • by Firstword Pharma

MS medical affairs: oral therapies outperforming in Europe. How does your team measure up? In Europe’s Multiple Sclerosis (MS) market, medical affairs teams for oral therapies outperform their platform-therapy ...

  • Industries : Biopharmaceutical
  • Countries : Europe
Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies

  • $ 6 995
  • Industry report
  • June 2016
  • by GBI Research

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies Summary Hematological malignancies are a class of cancer that affect the ...

  • Industries : Cancer, Pathology
  • Countries : World
Cardiac Biomarkers: Technologies and Global Markets

Cardiac Biomarkers: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2016
  • by BCC Research

This BCC Research report provides a comprehensive analysis of the cardiac biomarker market and its trends from 2014 through 2020. It details the history and current state of cardiovascular diseases (CVDs), ...

  • Industries : Genomics
  • Countries : World
Biomarkers: Technologies and Global Markets

Biomarkers: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2016
  • by BCC Research

This BCC Research study provides a comprehensive analysis of biomarkers on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to overall ...

  • Industries : Genomics
  • Countries : World
DNA Sequencing: Emerging Technologies and Applications

DNA Sequencing: Emerging Technologies and Applications

  • $ 6 650
  • Industry report
  • May 2016
  • by BCC Research

This BCC Research report provides a comprehensive discussion of sequencing technologies, market applications, industry structure, important clinical sequencing initiatives, global markets, and companies. ...

  • Industries : Genomics
  • Countries : World
About 19 000 reports

Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • August 2016
    13 pages
  • Vaccine  

    HPV Vaccine  

  • United States  

View report >

Protein Industry

August 2016

Enzyme Industry

August 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.